Abivax: Going It Alone At A Premium (Rating Downgrade)
Source: SeekingAlpha
2026-03-25 09:40:04 ET
Overview
To the dismay of many retail investors, Abivax ( ABVX ) remains a standalone company despite a flurry of rumors . I didn’t mind this much when I last assessed the stock (“ Buy ”) in January....
Read the full article on Seeking Alpha
For further details see:
Abivax: Going It Alone At A Premium (Rating Downgrade)
Abivax SA
NASDAQ: ABVX
ABVX Trading
-1.12% G/L:
$101.1001 Last:
364,837 Volume:
$103.50 Open:
ABVX Latest News
March 23, 2026 04:05:00 pm
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
ABVX Stock Data
$9,359,969,582
53,161,297
N/A
64
N/A
Biotechnology & Life Sciences
Healthcare
FR
Paris
